SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Aptose Biosciences Inc. (APTO) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 43/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — APTO
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-10.41
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-16.31 |
$0.00 |
$-13.86M |
- |
| 2017 |
$-7.84 |
$0.00 |
$-11.66M |
- |
| 2018 |
$-12.97 |
$0.00 |
$-28.87M |
- |
| 2019 |
$-7.86 |
$0.00 |
$-26.28M |
- |
| 2020 |
$-9.30 |
$0.00 |
$-55.24M |
- |
| 2021 |
$-11.01 |
$0.00 |
$-65.35M |
- |
| 2022 |
$-6.80 |
$0.00 |
$-41.82M |
- |
| 2023 |
$-7.58 |
$0.00 |
$-51.21M |
- |
| 2024 |
$-18.94 |
$0.00 |
$-25.43M |
- |
| 2025 |
$-10.41 |
$0.00 |
$0.00 |
- |
